Precigen (PGEN) Land & Improvements (2013 - 2026)
Precigen's (PGEN) quarterly Land & Improvements came in at $2.4 million in Q1 2026, up 1374.39% year-on-year from $164000.0 in Q1 2025, and little changed on a QoQ basis from $2.4 million in Q4 2025.
Precigen (PGEN) Land & Improvements (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Land & Improvements data on file, last reported at $2.4 million in Q1 2026.
- On a quarterly basis, Land & Improvements rose 1374.39% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 1374.39% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, down 24.42% from the prior year.
- Land & Improvements for Q1 2026 stood at $2.4 million, roughly flat from $2.4 million in the prior quarter.
- Over the last five years, Land & Improvements for PGEN reached as high as $5.2 million in Q1 2022 and fell as low as $164000.0 in Q2 2022.
- Historically, Land & Improvements has averaged $1.8 million across 5 years, with a median of $164000.0 in 2022.
- Across the five-year window, Land & Improvements tumbled 97.15% in 2022 and jumped 1374.39% in 2026, its largest moves.
- Year by year, Land & Improvements stood at $4.6 million in 2022, then declined by 24.18% to $3.5 million in 2023, then dropped by 7.89% to $3.2 million in 2024, then declined by 24.42% to $2.4 million in 2025, then rose by 0.42% to $2.4 million in 2026.
- Per Business Quant data, the three most recent Land & Improvements figures were $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $164000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 2.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.42 Mn |
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | 164,000.00 |
| Jun 30, 2025 | 164,000.00 |
| Mar 31, 2025 | 164,000.00 |
| Dec 31, 2024 | 3.19 Mn |
| Sep 30, 2024 | 164,000.00 |
| Jun 30, 2024 | 164,000.00 |
| Mar 31, 2024 | 3.48 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Sep 30, 2023 | 164,000.00 |
| Jun 30, 2023 | 164,000.00 |
| Mar 31, 2023 | 4.61 Mn |
| Dec 31, 2022 | 4.56 Mn |
| Sep 30, 2022 | 164,000.00 |
| Jun 30, 2022 | 164,000.00 |
| Mar 31, 2022 | 5.17 Mn |
| Dec 31, 2021 | 4.82 Mn |
| Sep 30, 2021 | 5.43 Mn |
| Jun 30, 2021 | 5.75 Mn |